Abstract
We describe 4 cases of zygomycosis that occurred after prolonged use of voriconazole in severely immunocompromised patients with hematologic disease. An invasive infection was present in 3 patients who died soon after the diagnosis at 12, 13, and 45 days. Physicians should be mindful of this potential risk after treatment with voriconazole.
MeSH terms
-
Absidia / isolation & purification
-
Adult
-
Antifungal Agents / therapeutic use*
-
Child, Preschool
-
Female
-
Hematologic Diseases / complications*
-
Humans
-
Immunocompromised Host*
-
Male
-
Middle Aged
-
Mucormycosis / drug therapy
-
Mucormycosis / microbiology*
-
Mucormycosis / mortality
-
Mucormycosis / surgery
-
Pyrimidines / therapeutic use*
-
Rhizomucor / isolation & purification
-
Rhizopus / isolation & purification
-
Time Factors
-
Treatment Outcome
-
Triazoles / therapeutic use*
-
Voriconazole
Substances
-
Antifungal Agents
-
Pyrimidines
-
Triazoles
-
Voriconazole